-
公开(公告)号:US20240392266A1
公开(公告)日:2024-11-28
申请号:US18694726
申请日:2022-06-22
Applicant: DAAN GENE CO., LTD.
Inventor: Xiwen JIANG , Aishan LIU , Wei ZHANG , Xiaocheng XIE , Xuelan LU
Abstract: Provided are a Taq polymerase mutant, a preparation method therefor and the use thereof. The Taq polymerase mutant includes an amino acid sequence having at least 70% identity to the amino acid sequence shown in SEQ ID NO:2, wherein the amino acid sequence has mutations occurring at one or more positions selected from the group consisting of: P40, L125, G200, D335, G499, E634, F769 or a combination thereof. The provided Taq polymerase mutant has high amplification activity, can obtain more amplification products compared with wild-type Taq polymerase under the same number of PCR cycles, and moreover, is resistant to whole blood and high salt and has low 5′-3′ exonuclease activity.
-
公开(公告)号:US20230390768A1
公开(公告)日:2023-12-07
申请号:US18057722
申请日:2022-11-21
Applicant: DAAN GENE CO., LTD.
Inventor: XIWEN JIANG , LINBO LIU , HAITAO SHU , JUNJIE LI
IPC: B01L3/00
CPC classification number: B01L3/502746 , B01L3/502707 , B01L2300/0877 , B01L2300/18
Abstract: A microfluidic chip-equipped detection cassette includes a housing, provided with a functional chamber, a first flow channel assembly, a second flow channel assembly, and a result display assembly, wherein the first flow channel assembly and the second flow channel assembly are both in communication with the functional chamber, the functional chamber is in communication with the result display assembly, and the result display assembly is configured to display a detection result.
-
公开(公告)号:US20250002986A1
公开(公告)日:2025-01-02
申请号:US18713019
申请日:2022-07-04
Applicant: DAAN GENE CO., LTD.
Inventor: Xiwen JIANG , Xianlan LIAN , Xiaocheng XIE , Xuelan LU , Haojian XU
IPC: C12Q1/6851
Abstract: Provided in the present invention is a method for preparing a constant-temperature amplification mixed enzyme system. Specifically, disclosed in the present invention is a method comprising: removing the vast majority of glycerol from a prepared glycerol-containing RPA enzyme system by means of dialysis, and then concentrating the enzyme system containing trace glycerol by using an ultrafiltration method. Experiments show that the amplification performance of an RPA mixed enzyme system prepared by means of such method is significantly improved.
-
公开(公告)号:US20230152315A1
公开(公告)日:2023-05-18
申请号:US17721382
申请日:2022-04-15
Applicant: DAAN GENE CO., LTD.
Inventor: Xiwen Jiang , Wenchuang Qi , Shuang Liu , Xiuhua Pan , Songkang Su , Hong Xu
IPC: G01N33/569 , G01N33/577 , G01N33/558 , G01N33/543
CPC classification number: G01N33/56983 , G01N33/577 , G01N33/558 , G01N33/54388 , G01N2333/165
Abstract: Disclosed is a kit for testing a COVID-19 antigen. The kit includes a test card, a conjugate pad and a reaction pad being arranged on the test card; wherein the conjugate pad is provided with a labeled antibody Ab1 and a labeled antibody Ab3 of the COVID-19 antigen, and a quality control line and a test line are arranged in parallel with an interval on the reaction pad, the test line being provided with a coating antibody Ab2, and the quality control line being provided with a coating antibody Ab4. With the kit, by the AIE immunofluorescence chromatographic technique, the AIE fluorescent microspheres are used as labels, and the test result of the test card is directly determined and read by using a fluorescent flashlight, or the test result is read by using a fluorescent tester. Such kits have the advantages of high sensitivity, strong specificity and simple operation.
-
公开(公告)号:US20230070496A1
公开(公告)日:2023-03-09
申请号:US17760195
申请日:2020-12-30
Applicant: Daan Gene Co., Ltd.
Inventor: Xiwen JIANG , Jian FAN , Hailong PENG
IPC: C12Q1/70 , C12Q1/686 , C12Q1/6876
Abstract: Provided is a nucleic acid detection kit for novel coronavirus 2019-nCoV, and in particular, provided are a kit and a method for multiple detection of the nucleic acid of the novel coronavirus 2019-nCoV. Three nucleic acid targets of the novel coronavirus 2019-nCoV can be detected at the same time. False positives can be prevented by means of mutual authentication among different targets, and detection omissions, which may be caused by mutations, are confirmed, such that the accuracy of virus identification is significantly improved.
-
公开(公告)号:US20240254460A1
公开(公告)日:2024-08-01
申请号:US17254376
申请日:2020-11-13
Applicant: Daan Gene Co., Ltd.
Inventor: Xiwen JIANG , Aishan LIU , Zhouquan WANG , Sangsang ZHENG , Jiguang ZHAO , Xianlan LIAN , Xiaocheng XIE , Xuelan LU , Wei ZHANG , Haojian XU , Zhikeng FANG , Zhijian WU
CPC classification number: C12N9/1276 , C12N15/1096 , C12Y207/07049
Abstract: The present invention provides a high temperature resistant reverse transcriptase mutant and its use. In particular, the present invention constructs a reverse transcriptase (M-MLV) mutant library, and the mutants with improved thermostability and higher amplification efficiency are finally screened out by stepwise screening. Under high temperature conditions, the reverse transcription efficiency of the reverse transcriptase mutant of the present invention is greatly improved compared to the wild type.
-
公开(公告)号:US20240002960A1
公开(公告)日:2024-01-04
申请号:US18245822
申请日:2020-11-10
Applicant: Daan Gene Co., Ltd.
Inventor: Xiwen JIANG , Taosheng HUANG , Xinyu LI , Zhiwen HUANG , Weiping LIN
IPC: C12Q1/70
CPC classification number: C12Q1/701 , C12Q2600/16
Abstract: Provided in the present invention are a method and a kit for multiple detection of respiratory virus nucleic acids, and in particular, disclosed are a method, a primer, a probe and a kit for detecting a plurality of influenza A viruses such as H1N1(2019), H3N2, H5N1, H1N1 and H7N9, influenza B viruses such as Yamagata and Victoria, 2019-nCoV OFR1ab and N genes, and human internal standard gene GAPDH on the basis of a real-time fluorescent quantitative PCR technical platform.
-
8.
公开(公告)号:US20230383222A1
公开(公告)日:2023-11-30
申请号:US18061481
申请日:2022-12-05
Applicant: DAAN GENE CO., LTD.
Inventor: XIWEN JIANG , LINBO LIU , HAITAO SHU , JUNJIE LI
CPC classification number: C12M1/24 , C12Q1/68 , B01L3/50273 , B01L2200/10 , B01L2200/0689
Abstract: Disclosed are a hand-held nucleic acid detection apparatus equipped with microfluidic chip, and a use method thereof. The detection apparatus includes a sample collection tube, a chip connector, and a detection chip. The chip connector is provided with a piercing tube configured to pierce the sample collection tube. The detection chip is connected to the chip connector. The detection chip is provided with a plurality of chambers and a plurality of flow channels. The flow channels are in communication with the piercing tube and the chambers. The reaction reagent and all the reaction processes are integrated on a chip, with no need of solution injection by virtue of an external instrument, solution transfer or the like operations, and the nucleic acid detection may be carried out even in the case of no dedicated experiment sites or special conditions.
-
公开(公告)号:US11649511B2
公开(公告)日:2023-05-16
申请号:US16760945
申请日:2020-04-10
Applicant: DAAN Gene Co., Ltd.
Inventor: Xiwen Jiang , Jian Fan , Hailong Peng , Rongyu Peng
IPC: C12Q1/70
CPC classification number: C12Q1/701 , C12N2770/20011 , C12Q2537/143 , C12Q2600/16
Abstract: The present invention provides a novel coronavirus duplex detection kit. Specifically, the present invention discloses a kit and method for multiplex detection of novel coronavirus 2019-nCoV nucleic acid, which can simultaneously detect two nucleic acid targets of the novel coronavirus 2019-nCoV and possess extremely high sensitivity and specificity, and significantly improve the accuracy of virus identification.
-
公开(公告)号:US20230115749A1
公开(公告)日:2023-04-13
申请号:US17726486
申请日:2022-04-21
Applicant: DAAN GENE CO., LTD.
Inventor: Xiwen Jiang , Wenchuang Qi , Runfeng Wu , Shaoqing Duan , Junxing Jian , Xue Diao
Abstract: The embodiments of the present application, belonging to the technical field of medical test and assay, and provide a preservative for an in vitro diagnostic reagent. The preservative includes a combination of a sulfadoxine solution and a dimethoprim solution, wherein a molar ratio of sulfadoxine in the sulfadoxine solution to dimethoprim in the dimethoprim solution is from 0.002 to 1. The present disclosure also provides use of the preservative for the in vitro diagnostic reagent. The technical solutions according to the embodiments of the present disclosure improve stability of the reagent, do not affect reactions of the reagent, and may be extensively applied.
-
-
-
-
-
-
-
-
-